TG Therapeutics Inc TGTX Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
TG Therapeutics Inc (TGTX)
TG Therapeutics Inc (TGTX) Financials

TG Therapeutics Inc (TGTX)

17.65

0.67

(3.95%)

Closed June 23 3:00PM

Delayed by 15 minutes

17.75

0.10

(0.57%)

After Hours: 6:51PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-93.017	-155.721	-191.695	-140.187	-70.85	-69.255	-69.203	4.844
Return on Equity (%)	-113.871	-230.361	-381.158	-551.854	-100.143	-92.029	-134.128	11.568
Return on Invested Capital (%)	-145.034	-244.633	-412.893	-399.157	-93.065	-87.387	-101.568	10.833
Operating Margin (%)	-51482.237	-77944.737	-114132.895	-110252.632	-179639.474	-5119.794	-6755.619	10.989
Net Profit Margin (%)	-51482.237	-77944.737	-114132.895	-113730.921	-183803.289	-5204.081	-7121.544	5.423
Book Value Per Share	0.558	0.835	0.258	0.327	3.535	1.582	0.379	0.995
Earnings Per Share	-1.244	-1.495	-1.928	-1.497	-1.904	-2.33	-1.3	0.079
Cash Per Share	0.398	0.716	0.466	0.975	3.773	2.001	0.671	0.579
Working Capital Per Share	0.54	0.825	0.446	0.56	3.573	1.778	0.755	1.646
Operating Profit Per Share	0.002	0.002	0.002	0.001	0.001	0.041	0.017	1.369
EBIT Per Share	-1.244	-1.495	-1.928	-1.497	-1.904	-2.33	-1.3	0.081
EBITDA Per Share	-1.244	-1.495	-1.928	-1.497	-1.904	-2.33	-1.3	0.081
Free Cash Flow Per Share	-1.24	-1.496	-1.928	-1.496	-1.903	-2.33	-1.302	0.078

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	3.013	3.338	2.034	1.766	6.987	5.062	3.163	5.919
Quick Ratio	2.659	3.03	1.771	1.663	6.915	4.835	3.039	5
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	62.207
Shares Outstanding	56.78M	73.14M	83.87M	109.38M	140.58M	143.25M	146.39M	154.42M

Key Stats and Ratios

Year End December 30 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	145.16M	145.36M	146.39M	N/A	N/A	N/A	154.42M	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-466.333	N/A	N/A	N/A	-13.218
Net Profit Margin (%)	N/A	N/A	N/A	-502.781	N/A	N/A	N/A	-16.868
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	2.93	N/A	N/A	N/A	3.617
Quick Ratio	N/A	N/A	N/A	2.352	N/A	N/A	N/A	2.756
Inventory Turnover (Days)	N/A	N/A	N/A	1273.313	N/A	N/A	N/A	446.914

Key Stats and Ratios

Market Cap	2.73B
Price to Earnings Ratio	215.12
Price to Sales Ratio	11.67
Price to Cash Ratio	29.34
Price to Book Ratio	16.99
Dividend Yield	-

Share Statistics

Shares Outstanding	154.54M
Average Volume (1 week)	2.01M
Average Volume (1 Month)	2.07M
52 Week Change	-25.81%
52 Week High	26.95
52 Week Low	6.46

More Ratios Coming Soon!

TG Therapeutics

AgileThought (CE)

AMUNDI JARH INAV

NLBNPIT1ZYD2 20991231 17...

Fauquier Bankshares

Societe Generale Effekten

Credit Agricole Financem...

Nord Pas De Calais RNORD...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions